Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 3
2004 6
2005 7
2006 5
2007 1
2008 11
2009 7
2010 6
2011 9
2012 12
2013 8
2014 10
2015 8
2016 10
2017 8
2018 7
2019 6
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

126 results
Results by year
Filters applied: . Clear all
Page 1
Management of patients with multidrug-resistant tuberculosis.
Lange C, Aarnoutse RE, Alffenaar JWC, Bothamley G, Brinkmann F, Costa J, Chesov D, van Crevel R, Dedicoat M, Dominguez J, Duarte R, Grobbel HP, Günther G, Guglielmetti L, Heyckendorf J, Kay AW, Kirakosyan O, Kirk O, Koczulla RA, Kudriashov GG, Kuksa L, van Leth F, Magis-Escurra C, Mandalakas AM, Molina-Moya B, Peloquin CA, Reimann M, Rumetshofer R, Schaaf HS, Schön T, Tiberi S, Valda J, Yablonskii PK, Dheda K. Lange C, et al. Among authors: van leth f. Int J Tuberc Lung Dis. 2019 Jun 1;23(6):645-662. doi: 10.5588/ijtld.18.0622. Int J Tuberc Lung Dis. 2019. PMID: 31315696 Review.
Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol.
Kuil SD, Hidad S, Fischer JC, Harting J, Hertogh CM, Prins JM, van Leth F, de Jong MD, Schneeberger C. Kuil SD, et al. Among authors: van leth f. BMJ Open. 2019 Aug 10;9(8):e031269. doi: 10.1136/bmjopen-2019-031269. BMJ Open. 2019. PMID: 31401614 Free PMC article.
Testing for LTBI: more of the same or a step forward?
van Leth F, Sester M. van Leth F, et al. Int J Tuberc Lung Dis. 2018 Jun 1;22(6):591. doi: 10.5588/ijtld.18.0267. Int J Tuberc Lung Dis. 2018. PMID: 29862938 No abstract available.
Relapse-free cure from multidrug-resistant tuberculosis in Germany.
Heyckendorf J, van Leth F, Kalsdorf B, Olaru ID, Günther G, Salzer HJF, Terhalle E, Rolling T, Glattki G, Müller M, Schuhmann M, Avsar K, Lange C. Heyckendorf J, et al. Among authors: van leth f. Eur Respir J. 2018 Feb 21;51(2):1702122. doi: 10.1183/13993003.02122-2017. Print 2018 Feb. Eur Respir J. 2018. PMID: 29467205 Free article. Clinical Trial. No abstract available.
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.
Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Domínguez J, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens JP, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C; TBNET. Sester M, et al. Among authors: van leth f. Am J Respir Crit Care Med. 2014 Nov 15;190(10):1168-76. doi: 10.1164/rccm.201405-0967OC. Am J Respir Crit Care Med. 2014. PMID: 25303140 Clinical Trial.
Treatment responses in multidrug-resistant tuberculosis in Germany.
Heyckendorf J, van Leth F, Avsar K, Glattki G, Günther G, Kalsdorf B, Müller M, Olaru ID, Rolling T, Salzer HJF, Schuhmann M, Terhalle E, Lange C. Heyckendorf J, et al. Among authors: van leth f. Int J Tuberc Lung Dis. 2018 Apr 1;22(4):399-406. doi: 10.5588/ijtld.17.0741. Int J Tuberc Lung Dis. 2018. PMID: 29562987 Free article. Clinical Trial.
Bridging the TB data gap: in silico extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data.
Ng KCS, Ngabonziza JCS, Lempens P, de Jong BC, van Leth F, Meehan CJ. Ng KCS, et al. Among authors: van leth f. PeerJ. 2019 Aug 26;7:e7564. doi: 10.7717/peerj.7564. eCollection 2019. PeerJ. 2019. PMID: 31523514 Free PMC article.
Treatment Outcomes in Multidrug-Resistant Tuberculosis.
Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBNET. Günther G, et al. Among authors: van leth f. N Engl J Med. 2016 Sep 15;375(11):1103-5. doi: 10.1056/NEJMc1603274. N Engl J Med. 2016. PMID: 27626539 Free article. Clinical Trial. No abstract available.
Time to revise WHO-recommended definitions of MDR-TB treatment outcomes.
Lange C, van Leth F, Mitnick CD, Dheda K, Günther G. Lange C, et al. Among authors: van leth f. Lancet Respir Med. 2018 Apr;6(4):246-248. doi: 10.1016/S2213-2600(18)30104-8. Lancet Respir Med. 2018. PMID: 29595505 No abstract available.
Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.
Lange C, Duarte R, Fréchet-Jachym M, Guenther G, Guglielmetti L, Olaru ID, Oliveira O, Rumetshofer R, Veziris N, van Leth F; European MDR-TB database collaboration *. Lange C, et al. Among authors: van leth f. Am J Respir Crit Care Med. 2016 Oct 15;194(8):1029-1031. doi: 10.1164/rccm.201606-1097LE. Am J Respir Crit Care Med. 2016. PMID: 27685538 No abstract available.
126 results
Jump to page
Feedback